The Bionaut Team

MichaelShpigelmacher

Michael Shpigelmacher

CEO and Founder

Robotics/AI expert with specialty in R&D moonshot projects. Two decades of innovation leadership at Government of Israel, PrimeSense (acquired by Apple), McKinsey, Morgan Stanley.

William Louden

William Loudon, MD, PhD

VP Neuroscience

Board certified General and Pediatric Neurosurgeon, 20 years of clinical and biomedical research experience. Graduate training at NINCDS/NIH and MD Anderson Cancer Institute. Clinical focus: stereotactic surgery and radiosurgery, endoscopic surgery and other novel approaches for the treatment of complex hydrocephalus, brain tumors and neuro-trauma.

Alex Kiselyov

Chief Science Officer

An expert in Drug Development with decades of experience across multiple therapeutic areas at Amgen, Lilly and others, holder of multiple patents.

Alicia Chung

Alicia Chung, PhD

SVP of Business Development and Strategy

Corporate strategy and business development expert who previously served as Head of Corporate Development at Amphivena Therapeutics, Inc., a clinical stage immunotherapy company, and led Strategy and Business Development at Halozyme Therapeutics. Alicia began her career at Roche-Genentech, where she held positions of increasing responsibility in R&D, commercial and business development and licensing.

Daniel Geffken

Daniel Geffken

Interim CFO

Proven leader of life science companies with more than 30 years of strategy, finance and operations experience across all stages of the corporate life cycle. As co-founder and Managing Director of Danforth Advisors, Daniel has served as CFO or executive-level advisor to numerous companies, including Apellis Pharmaceuticals, Century Therapeutics, Atea, Cidara, Editas Medicine, Homology Medicines, Promedior, Elicio Therapeutics and Prilenia.

Aviad Maizels

Aviad Maizels

Executive Chairman and Founder

Former CEO and Founder of PrimeSense (acquired by Apple), serial entrepreneur and the visionary behind the Bionaut concept. World Economic Forum Technology Pioneer, International Board Member of the Weizmann Institute of Science.

MichaelShpigelmacher

Michael Shpigelmacher

CEO and Founder

Robotics/AI expert with specialty in R&D moonshot projects. Two decades of innovation leadership at Government of Israel, PrimeSense (acquired by Apple), McKinsey, Morgan Stanley.

Alex Shpunt

Alex Shpunt

Founder

Former Co-Founder and CTO of PrimeSense (acquired by Apple), an award-winning technologist and inventor of multiple patents.

MichaelShpigelmacher

Michael Shpigelmacher

CEO and Founder

Robotics/AI expert with specialty in R&D moonshot projects. Two decades of innovation leadership at Government of Israel, PrimeSense (acquired by Apple), McKinsey, Morgan Stanley.

Aviad Maizels

Aviad Maizels

Executive Chairman and Founder

Former CEO and Founder of PrimeSense (acquired by Apple), serial entrepreneur and the visionary behind the Bionaut concept. World Economic Forum Technology Pioneer, International Board Member of the Weizmann Institute of Science.

Kevin Zhang

Kevin Zhang

Partner, Upfront Ventures

Partner at Upfront Ventures, BS Biology, Neuroscience from Harvard. 10+ years in healthcare and tech operations and investing.

Samir Kaul

Samir Kaul

Managing Partner, Khosla Ventures

Samir is a founding general partner at Khosla Ventures, where he focuses on health, sustainability, food and advanced technology investing.

Errol DeSouza

Errol De Souza, PhD

Independent board member – Industry expert

Dr. De Souza has substantial experience as an executive in the biopharmaceutical industry, having founded and served as Executive Chairman for a number of successful companies. He has worked in senior leadership roles across multiple pharmaceutical companies, including Neurocrine, Aventis and Merck.

Errol DeSouza

Errol De Souza, PhD

Independent board member – Industry expert

Dr. De Souza has substantial experience as an executive in the biopharmaceutical industry, having founded and served as Executive Chairman for a number of successful companies. He has worked in senior leadership roles across multiple pharmaceutical companies, including Neurocrine, Aventis and Merck.

Gary Schwartz

Dr. Gary Schwartz, MD

Senior Medical Advisor

World-renowned Oncology KOL, Head of Oncology/Hematology at Columbia University. Previously Chief of the Melanoma Sarcoma Oncology Service at Memorial Sloan-Kettering. Member of White House Cancer Moonshot Initiative 2020. Co-editor, Journal of Clinical Oncology and Clinical Cancer Research.

Jay Kranzler

Jay D Kranzler, MD, PhD

Senior Medical Advisor

Jay D Kranzler, MD, PhD has been a Founder, CEO, Board Member, and Advisor to leading life science companies for over 30 years, most recently serving as Global Head of External R&D Innovation for Pfizer. He also provides consulting services to multiple biotechnology companies, investment banks, and investors.

Santoch Kesari

Dr. Santosh Kesari, MD

Neurology Advisor

Board-certified neurologist and neuro-oncologist, currently Chair and of Neurosciences and Neurotherapeutics, John Wayne Cancer Institute. Internationally recognized clinician, serving on multiple medical advisory boards, and author of over 250 scientific publications, reviews, and books.

John Crawford

John Crawford, MD

Neurology Advisor

Dr. Crawford is Professor of Clinical Neurosciences and Pediatrics at the University of California San Diego where he is Director of Clinical Pediatric Neuro-oncology Research and Director of the Pediatric Neuro-Oncology Fellowship.

Chetan Bettegowda

Dr. Chetan Bettegowda, MD

Neurosurgery Advisor

Associate Professor of Oncology and Neurosurgery at Johns Hopkins. Specializes in comprehensive treatments for adult patients with benign and malignant brain tumors, with a focus on treatment of patients with primary brain tumors, such as gliomas, meningiomas and pituitary tumors.

Jason Sager

Dr. Jason Sager, MD

Oncology Advisor

Accomplished oncologist, 20 years of clinical and drug development experience at Johns Hopkins, Dana Farber, Genentech, Novartis, Sanofi (former Head of Early Oncology Development). Directly managed 10 INDs and clinical trials.

Eldad Elnekave

Dr. Eldad Elnekave, MD

Interventional Radiology Advisor

Expert interventional radiologist and biotech entrepreneur. Completed Interventional Radiology training at Memorial-Sloan Kettering Cancer Center and practices clinically as the Director of the Interventional Oncology clinic at Davidoff Oncology Center. Expert in the usage of advanced AI techniques on the field of medical imaging.

Anita Gupta

Dr. Anita Gupta, MD

Pain Management/ Anesthesiology Advisor

Expert in pain management and a thought leader, featured as speaker on CNN, Forbes and others. Healthcare provider for over 20 years, served as advisor to the FDA, received the Learner Award from AAMC, and authored multiple books. PhD in Pharmacy at Rutgers University, MD from UMDNJ (now Rowan University), residency in anesthesiology at Georgetown.

Ehsan Saadat

Dr. Ehsan Saadat, MD

Spinal Surgery Advisor

Orthopaedic surgeon with experience in treatment of challenging spinal deformities, motion-preserving cervical laminoplasty, as well as minimally invasive surgery. BS in BioEngineering from UC Berkeley, MD from UCSF, orthopaedic surgical residency at Harvard, spine surgery fellowship at Emory Spine Center.

Houman Hemmati

Dr. Houman David Hemmati

Ophthalmology Advisor

Ophthalmology expert, presently serving as Adjunct Assistant Clinical Professor of Ophthalmology at USC. Previously served as Assistant Professor of Ophthalmology at the University of Vermont. Co-founded several biopharmaceutical ventures. Also served as Director, Clinical Development at Allergan, and Clinical Scientist on several Phase 1, 2, and 3 studies.

coming soon

Dr. Meeta Patnaitk, MD

Senior Medical Advisor

Precision Medicine expert and serial biotech entrepreneur with multiple $B exits. Former CMO of LabCorp, Entrepreneur in Residence at Children's Hospital LA.

Aya Jakobovits, Ph.D.

Aya Jakobovits, Ph.D.

Senior Corporate Advisor

An accomplished biotech executive with extensive track record in starting and growing biotech companies in the targeted immunotherapy area, based on novel technologies therapeutic products, including Founder and CEO of Adicet bio, Founding CEO of Kite Pharma (acquired by Gilead for $1.9B), CSO and SVP corporate development at Agensys and EVP and Head R&D at Astellas (acquired Agensys for $537M), Director and leader of XenoMouse technology at Cell Genesys/Abgenix (acquired by Amgen for $2.2B).

Susan Alpert

Dr. Susan Alpert, MD

Senior Regulatory Advisor

Worldwide expert in Regulatory Affairs with a focus on Medical Devices. Held senior positions at the FDA, including Director of the FDA’s Office of Device Evaluation. Also senior vice president and chief regulatory officer at Medtronic until 2012, and had similar role at C.R. Bard.

Marleve Haffner

Marlene E Haffner, MD, MPH

Senior Regulatory Advisor

CEO of Haffner Associates, LLC a firm dedicated to the strategy, development and policy of drug development with a special emphasis on rare diseases and the products that treatment them. For 20 years, Dr. Haffner served as Director of the Office of Orphan Products Development (OOPD) of the Food and Drug Administration (FDA).

Benny Zeevi

Dr. Benny Zeevi, MD

Senior Medical/Business Advisor

Managing General Partner in DFJ Tamir Fishman Venture and Tel Aviv Venture Partners, Co-Chairperson of Israel Advanced Technology Industries (IATI). Physician specializing in interventional pediatric cardiology. Vast experience includes the Schneider Children’s Medical Center in Israel and Children’s Hospital in Boston.

Peer Fischer

Prof. Peer Fischer, PhD

Senior Scientific Advisor

Original inventor of Bionaut technology, Head of Micro, Nano and Molecular Systems Lab at Max Planck Institute for Intelligent Systems. Formerly NATO Postdoctoral Fellow at Cornell and leader of research group at Harvard University. Recipient of Fraunhofer Attract award and ERC grant holder.